Vivek C. Goodoory, Christy Riggott, Mais Khasawneh, Christopher J. Black, Alexander C. Ford
{"title":"Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care","authors":"Vivek C. Goodoory, Christy Riggott, Mais Khasawneh, Christopher J. Black, Alexander C. Ford","doi":"10.1111/apt.18363","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The Rome IV criteria for irritable bowel syndrome (IBS) may be too restrictive for clinical practice and research.</p>\n </section>\n \n <section>\n \n <h3> Aims</h3>\n \n <p>To validate the Rome IV criteria and study the diagnostic performance of simple modifications to them.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We collected symptom data from consecutive adults with suspected IBS seen in a single clinic. We used a reference standard to confirm IBS (presence of lower abdominal pain associated with altered stool form or frequency; no evidence of organic gastrointestinal disease after limited investigation). We applied Rome IV criteria, but also two modifications. First, we re-incorporated abdominal discomfort but kept symptom frequency required for both abdominal pain and discomfort to at least 1 day per week. Second, we included only abdominal pain but relaxed symptom frequency back to 3 days per month. We calculated sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% confidence intervals (CIs), for each diagnostic criterion.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We recruited 170 patients (76.5% female, mean age 37.9 years). Sensitivity and specificity of the Rome IV criteria were 82.1% and 85.1%, respectively; positive and negative LRs were 5.51 (95% CI 2.95–11.3) and 0.21 (95% CI 0.14–0.31), respectively. Modifying the criteria by relaxing the frequency of abdominal pain to 3 days per month led to the best performance [sensitivity 90.2%, specificity 85.1%, positive LR 6.06 (95% CI 3.25–12.2), and negative LR 0.11 (95% CI 0.07–0.19)].</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The Rome IV criteria performed well in diagnosing IBS. A simple modification relaxing the required frequency of abdominal pain improved their performance.</p>\n </section>\n </div>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 2","pages":"354-362"},"PeriodicalIF":6.7000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671724/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18363","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The Rome IV criteria for irritable bowel syndrome (IBS) may be too restrictive for clinical practice and research.
Aims
To validate the Rome IV criteria and study the diagnostic performance of simple modifications to them.
Methods
We collected symptom data from consecutive adults with suspected IBS seen in a single clinic. We used a reference standard to confirm IBS (presence of lower abdominal pain associated with altered stool form or frequency; no evidence of organic gastrointestinal disease after limited investigation). We applied Rome IV criteria, but also two modifications. First, we re-incorporated abdominal discomfort but kept symptom frequency required for both abdominal pain and discomfort to at least 1 day per week. Second, we included only abdominal pain but relaxed symptom frequency back to 3 days per month. We calculated sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% confidence intervals (CIs), for each diagnostic criterion.
Results
We recruited 170 patients (76.5% female, mean age 37.9 years). Sensitivity and specificity of the Rome IV criteria were 82.1% and 85.1%, respectively; positive and negative LRs were 5.51 (95% CI 2.95–11.3) and 0.21 (95% CI 0.14–0.31), respectively. Modifying the criteria by relaxing the frequency of abdominal pain to 3 days per month led to the best performance [sensitivity 90.2%, specificity 85.1%, positive LR 6.06 (95% CI 3.25–12.2), and negative LR 0.11 (95% CI 0.07–0.19)].
Conclusions
The Rome IV criteria performed well in diagnosing IBS. A simple modification relaxing the required frequency of abdominal pain improved their performance.
背景:目的:验证罗马 IV 标准,并研究对其进行简单修改后的诊断效果:我们收集了在一家诊所就诊的疑似肠易激综合征成人患者的症状数据。我们使用一个参考标准来确认肠易激综合征(出现下腹痛并伴有大便形状或次数改变;经过有限的检查后没有发现器质性胃肠道疾病的证据)。我们采用了罗马 IV 标准,但也做了两处修改。首先,我们重新纳入了腹部不适,但要求腹痛和腹部不适的症状频率至少为每周 1 天。其次,我们只纳入了腹痛,但将症状频率放宽到每月 3 天。我们计算了每种诊断标准的敏感性、特异性、阳性和阴性似然比 (LR),以及 95% 的置信区间 (CI):我们招募了 170 名患者(76.5% 为女性,平均年龄 37.9 岁)。罗马IV标准的敏感性和特异性分别为82.1%和85.1%;阳性和阴性LR分别为5.51(95% CI 2.95-11.3)和0.21(95% CI 0.14-0.31)。通过将腹痛频率放宽至每月 3 天来修改标准,结果显示该标准的性能最佳[灵敏度为 90.2%,特异性为 85.1%,阳性 LR 为 6.06 (95% CI 3.25-12.2),阴性 LR 为 0.11 (95% CI 0.07-0.19)]:罗马 IV 标准在诊断肠易激综合征方面表现良好。结论:罗马 IV 标准在诊断肠易激综合征方面表现良好,只需对腹痛频率的要求进行简单修改即可改善其表现。
期刊介绍:
Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.